Related Experiment Video
Updated: Jul 6, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
An update on cardioembolic stroke
1Calgary Stroke Program, Room 1079, Foothills Hospital, 1403-29th Street NW, Calgary, Alberta T2N 2T9, Canada. nic.weir@calgaryhealthregion.ca
Insights
Cardioembolic stroke, often caused by atrial fibrillation, is a significant concern. This review updates stroke prevention strategies for atrial fibrillation and other cardioembolic sources.
Area of Science:
- Neurology
- Cardiology
- Stroke Medicine
Background:
- Cardioembolic strokes account for approximately 20% of all ischemic strokes.
- Atrial fibrillation is the primary driver of cardioembolism, with significant advancements in understanding and treatment.
- Other cardioembolic disorders present ongoing challenges for stroke prevention.
Purpose of the Study:
- To review current diagnostic methods for cardioembolic stroke.
- To provide an update on evidence-based stroke prevention strategies.
- To discuss stroke prevention in the context of various cardioembolic conditions.
Main Methods:
- Literature review of diagnostic techniques for cardioembolic stroke.
- Synthesis of recent evidence on stroke prevention for atrial fibrillation.
- Review of stroke prevention in valvular heart disease, patent foramen ovale, and left ventricular dysfunction.
Main Results:
- Significant progress in understanding and treating atrial fibrillation-related cardioembolism.
- Less certainty and ongoing debate regarding stroke prevention for other cardioembolic causes.
- Established diagnostic and updated therapeutic approaches for cardioembolic stroke.
Conclusions:
- Atrial fibrillation management is key to reducing cardioembolic stroke risk.
- Further research is needed to clarify optimal stroke prevention for less common cardioembolic sources.
- A comprehensive approach integrating diagnostics and tailored prevention is crucial.
Abstract:
About one-fifth of all ischaemic strokes are cardioembolic. Recent years have seen considerable progress in our understanding of atrial fibrillation, the most important cause of cardioembolism, and evidence-based treatment strategies have emerged. Progress in relation to other cardioembolic disorders has been more limited and here stroke prevention strategies remain less certain and subject to debate. This article briefly reviews the methods currently used to identify and investigate cardioembolic stroke and then provides an update on stroke prevention in relation to atrial fibrillation, valvular heart disease, patent foramen ovale and left ventricular dysfunction (after myocardial infarction and chronic failure).
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Pulmonary Embolism I: Introduction